These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 8093660

  • 1. Resistance to tetracycline, a hydrophilic antibiotic, is mediated by P-glycoprotein in human multidrug-resistant cells.
    Kavallaris M, Madafiglio J, Norris MD, Haber M.
    Biochem Biophys Res Commun; 1993 Jan 15; 190(1):79-85. PubMed ID: 8093660
    [Abstract] [Full Text] [Related]

  • 2. Atypical multidrug resistance in a therapy-induced drug-resistant human leukemia cell line (LALW-2): resistance to Vinca alkaloids independent of P-glycoprotein.
    Haber M, Norris MD, Kavallaris M, Bell DR, Davey RA, White L, Stewart BW.
    Cancer Res; 1989 Oct 01; 49(19):5281-7. PubMed ID: 2569932
    [Abstract] [Full Text] [Related]

  • 3. Effect of duration of exposure to verapamil on vincristine activity against multidrug-resistant human leukemic cell lines.
    Cass CE, Janowska-Wieczorek A, Lynch MA, Sheinin H, Hindenburg AA, Beck WT.
    Cancer Res; 1989 Nov 01; 49(21):5798-804. PubMed ID: 2790792
    [Abstract] [Full Text] [Related]

  • 4. Lack of reversal of daunorubicin resistance in HL60/AR cells by cyclosporin A.
    Gollapudi S, Gupta S.
    Anticancer Res; 1992 Nov 01; 12(6B):2127-32. PubMed ID: 1363515
    [Abstract] [Full Text] [Related]

  • 5. Characterization of monoclonal antibodies recognizing a Mr 180,000 P-glycoprotein: differential expression of the Mr 180,000 and Mr 170,000 P-glycoproteins in multidrug-resistant human tumor cells.
    Meyers MB, Rittmann-Grauer L, O'Brien JP, Safa AR.
    Cancer Res; 1989 Jun 15; 49(12):3209-14. PubMed ID: 2566379
    [Abstract] [Full Text] [Related]

  • 6. Pharmacological, molecular, and cytogenetic analysis of "atypical" multidrug-resistant human leukemic cells.
    Beck WT, Cirtain MC, Danks MK, Felsted RL, Safa AR, Wolverton JS, Suttle DP, Trent JM.
    Cancer Res; 1987 Oct 15; 47(20):5455-60. PubMed ID: 2888532
    [Abstract] [Full Text] [Related]

  • 7. A non-P-glycoprotein-mediated mechanism of vincristine transport which is affected by resistance modifiers and present in chemosensitive cells.
    Gruber A, Larsson R, Nygren P, Björkholm M, Peterson C.
    Leukemia; 1994 Jun 15; 8(6):985-9. PubMed ID: 7911547
    [Abstract] [Full Text] [Related]

  • 8. Combined treatment of P-gp-positive L1210/VCR cells by verapamil and all-trans retinoic acid induces down-regulation of P-glycoprotein expression and transport activity.
    Sulová Z, Macejová D, Seres M, Sedlák J, Brtko J, Breier A.
    Toxicol In Vitro; 2008 Feb 15; 22(1):96-105. PubMed ID: 17920233
    [Abstract] [Full Text] [Related]

  • 9. Multidrug resistance in a human leukemic cell line selected for resistance to trimetrexate.
    Arkin H, Ohnuma T, Kamen BA, Holland JF, Vallabhajosula S.
    Cancer Res; 1989 Dec 01; 49(23):6556-61. PubMed ID: 2573416
    [Abstract] [Full Text] [Related]

  • 10. Cytogenetic and molecular characterization of tumors in nude mice derived from a multidrug-resistant human leukemia cell line.
    Hill AB, Beck WT, Trent JM.
    Cancer Res; 1988 Jan 15; 48(2):393-8. PubMed ID: 2891436
    [Abstract] [Full Text] [Related]

  • 11. Reversal mechanism of multidrug resistance by verapamil: direct binding of verapamil to P-glycoprotein on specific sites and transport of verapamil outward across the plasma membrane of K562/ADM cells.
    Yusa K, Tsuruo T.
    Cancer Res; 1989 Sep 15; 49(18):5002-6. PubMed ID: 2569930
    [Abstract] [Full Text] [Related]

  • 12. Reversal of Vinca alkaloid resistance but not multiple drug resistance in human leukemic cells by verapamil.
    Beck WT, Cirtain MC, Look AT, Ashmun RA.
    Cancer Res; 1986 Feb 15; 46(2):778-84. PubMed ID: 3455678
    [Abstract] [Full Text] [Related]

  • 13. Effect of phorbol myristate acetate (PMA) on P-glycoprotein mediated vincristine resistance of L1210 cells.
    Barancík M, Stefanková Z, Breier A.
    Gen Physiol Biophys; 1995 Apr 15; 14(2):171-5. PubMed ID: 8846884
    [Abstract] [Full Text] [Related]

  • 14. Cellular pharmacology of MX2, a new morpholino anthracycline, in human pleiotropic drug-resistant cells.
    Watanabe M, Komeshima N, Naito M, Isoe T, Otake N, Tsuruo T.
    Cancer Res; 1991 Jan 01; 51(1):157-61. PubMed ID: 1988080
    [Abstract] [Full Text] [Related]

  • 15. Cross-resistance of human multidrug-resistant cells to mitomycin C.
    Yusa K, Sato W, Yamazaki A, Tsukahara S, Tsuruo T.
    Anticancer Res; 1991 Jan 01; 11(3):1301-4. PubMed ID: 1909515
    [Abstract] [Full Text] [Related]

  • 16. Direct interaction between verapamil and doxorubicin causes the lack of reversal effect of verapamil on P-glycoprotein mediated resistance to doxorubicin in vitro using L1210/VCR cells.
    Breier A, Drobná Z, Barancík M.
    Neoplasma; 1998 Jan 01; 45(4):248-53. PubMed ID: 9890669
    [Abstract] [Full Text] [Related]

  • 17. A flow cell assay for evaluation of whole cell drug efflux kinetics: analysis of paclitaxel efflux in CCRF-CEM leukemia cells overexpressing P-glycoprotein.
    Lin JT, Sharma R, Grady JJ, Awasthi S.
    Drug Metab Dispos; 2001 Feb 01; 29(2):103-10. PubMed ID: 11159798
    [Abstract] [Full Text] [Related]

  • 18. Secretion of lysosomal enzymes by drug-sensitive and multiple drug-resistant cells.
    Warren L, Jardillier JC, Ordentlich P.
    Cancer Res; 1991 Apr 15; 51(8):1996-2001. PubMed ID: 1672622
    [Abstract] [Full Text] [Related]

  • 19. p170-dependent multidrug resistance. Restoring full sensitivity to idarubicin with verapamil and cyclosporin A derivatives.
    Michieli M, Damiani D, Michelutti A, Melli C, Russo D, Fanin R, Baccarani M.
    Haematologica; 1994 Apr 15; 79(2):119-26. PubMed ID: 7914881
    [Abstract] [Full Text] [Related]

  • 20. The multidrug-resistance modifiers verapamil, cyclosporine A and tamoxifen induce an intracellular acidification in colon carcinoma cell lines in vitro.
    Hamilton G, Cosentini EP, Teleky B, Koperna T, Zacheri J, Riegler M, Feil W, Schiessel R, Wenzi E.
    Anticancer Res; 1993 Apr 15; 13(6A):2059-63. PubMed ID: 7905252
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.